Actively Recruiting
A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
Led by Bristol-Myers Squibb · Updated on 2024-07-23
1500
Participants Needed
1
Research Sites
271 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to understand the comparative effectiveness of deucravacitinib versus apremilast in adults with plaque psoriasis.
CONDITIONS
Official Title
A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with plaque psoriasis by a dermatologist
- Newly starting treatment with either deucravacitinib or apremilast
- Actively enrolled in the CorEvitas Psoriasis Registry with consent for research use of registry data
You will not qualify if you...
- Currently participating or planning to participate in an interventional clinical trial (excluding observational studies)
- Restarting treatment with deucravacitinib or apremilast previously received at any time
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Local Institution
Waltham, Massachusetts, United States, 02451
Actively Recruiting
Research Team
B
BMS Study Connect Contact Center www.BMSStudyConnect.com
CONTACT
F
First line of the email MUST contain the NCT# and Site #.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here